Search Results - "Dantin, Carole"
-
1
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Published in Bone marrow transplantation (Basingstoke) (01-12-2021)Get full text
Journal Article -
2
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation
Published in Leukemia (01-05-2020)“…After allogeneic hematopoietic stem cell transplantation (HSCT), immune reconstitution leads to the development of a new T-cell repertoire. Immune…”
Get full text
Journal Article -
3
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation
Published in Frontiers in immunology (16-05-2019)“…Immune exhaustion contributes to treatment failure after allogeneic hematopoietic stem cell transplantation (HSCT) for hematological malignancies. Immune…”
Get full text
Journal Article -
4
Rhinovirus Infections among Hematopoietic Stem Cell Transplant Recipients: A Pre-Transplant Dilemma?
Published in Viruses (28-01-2022)“…Respiratory viral infections (RVIs) in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients can be of concern due to the patients' depressed…”
Get full text
Journal Article -
5
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation
Published in Frontiers in immunology (27-05-2020)“…Impaired immune reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT) contributes to increased risk of cancer relapse and infection…”
Get full text
Journal Article -
6
TNF Skews Monocyte Differentiation from Macrophages to Dendritic Cells
Published in The Journal of immunology (1950) (01-09-2003)“…Monocytes represent a large pool of circulating precursors of APCs, both macrophages and dendritic cells (DCs). It is thus important to identify the mechanisms…”
Get full text
Journal Article -
7
Allogeneic hematopoietic stem cell transplantation in non‐Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better
Published in EJHaem (01-02-2023)“…Due to relatively high nonrelapse mortality (NRM), allogeneic hematopoietic stem cell transplantation (allo‐HSCT) in non‐Hodgkin's lymphoma (NHL) remains the…”
Get full text
Journal Article -
8
Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Protects against Interleukin-3 Starvation but Not DNA Damage-induced Apoptosis
Published in The Journal of biological chemistry (06-04-2001)“…Baf-3 cells are dependent on interleukin-3 (IL-3) for their survival and proliferation in culture. To identify anti-apoptotic pathways, we performed a…”
Get full text
Journal Article -
9
Human NK cells can control CMV infection in the absence of T cells
Published in Blood (01-08-2008)Get full text
Journal Article -
10
IL‐15‐induced human DC efficiently prime melanoma‐specific naive CD8+ T cells to differentiate into CTL
Published in European Journal of Immunology (01-06-2007)“…Monocytes differentiate into dendritic cells (DC) in response to GM‐CSF combined with other cytokines including IL‐4 and IL‐15. Here, we show that IL15‐DC are…”
Get full text
Journal Article -
11
How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)
Published in Bulletin du cancer (01-01-2020)“…In an effort to standardize hematopoietic stem cell allograft procedures, the Francophone bone marrow transplantation and Cell Therapy Society (SFGM-TC)…”
Get full text
Journal Article -
12
Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Published in Bulletin du cancer (01-12-2020)“…Tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™) are the first two approved drug products that belong to of a new class of therapies…”
Get full text
Journal Article -
13
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
Published in Leukemia & lymphoma (04-03-2018)“…Graft-versus-host disease (GvHD)-free, relapse-free survival (GRFS) is a recently reported composite endpoint that allows to simultaneously estimate risk of…”
Get full text
Journal Article -
14
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study
Published in Transplantation and cellular therapy (01-11-2022)“…Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a well-known complication of allogeneic hematopoietic stem cell…”
Get full text
Journal Article -
15
Decreased Incidence of GvHD after Reduced Intensity Conditioning and a Fixed T-CELL Dose in Hematological Malingnancy Patients
Published in Blood (06-12-2014)“…Introduction: To decrease graft versus host disease (GvHD), the Geneva transplantation team has performed allogeneic hematopoietic stem cell (alloHSCT) with…”
Get full text
Journal Article -
16
T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Published in Blood (03-12-2015)“…Introduction: Allogeneic hematopoietic stem cell transplantation (HSCT) is a well-established therapeutic modality for a variety of hematological malignancies…”
Get full text
Journal Article -
17
Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Published in Blood (02-12-2016)“…Backgound: Sinusoidal obstruction syndrome [SOS, also known as hepatic veno-occlusive disease (VOD)] is frequent after HSCT and may have a mortality rate of up…”
Get full text
Journal Article -
18
-
19
FLT3 -ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission: Impact of partial T-cell depletion for AML with FLT3 -ITD
Published in Hematological oncology (01-09-2017)Get full text
Journal Article -
20